Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TNFRSF10A Antisense RNA 1 (TNFRSF10A-AS1) is a long noncoding RNA transcribed in antisense orientation to the TNFRSF10A gene, lying in a head-to-head arrangement and possibly sharing promoter elements[2]. It is primarily localized in the cytoplasm[2][3] and participates in regulating cell death (necroptosis), inflammation, and cancer cell behaviors. Enhanced expression of TNFRSF10A-AS1 has been robustly linked to increased cell proliferation, migration, and invasion in colorectal and gastric cancer. Mechanistically, TNFRSF10A-AS1 has been shown to act as a competitive endogenous RNA, sequestering miR-3121-3p and thereby upregulating HuR, a protein that promotes tumorigenesis[3]. While evidence suggests it can regulate inflammatory and necroptotic pathways, its precise function is still being elucidated, and it is considered a promising, emerging therapeutic target in oncology[3][7].
Acts as a molecular sponge for miR-3121-3p, regulating HuR expression and thereby promoting tumor cell proliferation and migration (in colorectal cancer)[3]. May regulate genes involved in necroptosis and inflammation, independently of TNFRSF10A[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TNFRSF10A antisense RNA 1 (TNFRSF10A-AS1).